Stevens Marc Y, Chow Shiao Y, Estrada Sergio, Eriksson Jonas, Asplund Veronika, Orlova Anna, Mitran Bogdan, Antoni Gunnar, Larhed Mats, Åberg Ola, Odell Luke R
Department of Medicinal Chemistry Division of Organic Pharmaceutical Chemistry Uppsala University 75123 Uppsala Sweden.
Department of Medicinal Chemistry Preclinical PET Platform Uppsala University 75183 Uppsala Sweden.
ChemistryOpen. 2016 Oct 5;5(6):566-573. doi: 10.1002/open.201600091. eCollection 2016 Dec.
We describe the development of a new methodology focusing on C-labeling of sulfonyl carbamates in a multicomponent reaction comprised of a sulfonyl azide, an alkyl alcohol, and [C]CO. A number of C-labeled sulfonyl carbamates were synthesized and isolated, and the developed methodology was then applied in the preparation of a biologically active molecule. The target compound was obtained in 24±10 % isolated radiochemical yield and was evaluated for binding properties in a tumor cell assay; in vivo biodistribution and imaging studies were also performed. This represents the first successful radiolabeling of a non-peptide angiotensin II receptor subtype 2 agonist, C21, currently in clinical trials for the treatment of idiopathic pulmonary fibrosis.
我们描述了一种新方法的开发,该方法聚焦于在由磺酰叠氮化物、烷基醇和[C]CO组成的多组分反应中对磺酰氨基甲酸酯进行碳-11标记。合成并分离出了多种碳-11标记的磺酰氨基甲酸酯,然后将所开发的方法应用于制备一种生物活性分子。目标化合物以24±10 %的分离放射化学产率获得,并在肿瘤细胞测定中评估其结合特性;还进行了体内生物分布和成像研究。这代表了首个成功对非肽类血管紧张素II受体2型激动剂C21进行放射性标记,该激动剂目前正处于治疗特发性肺纤维化的临床试验阶段。